Related references
Note: Only part of the references are listed.Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions
Daniel R. Migliozzi et al.
ANNALS OF PHARMACOTHERAPY (2020)
OPTN/SRTR 2018 Annual Data Report: Kidney
A. Hart et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease A Scientific Statement From the American Heart Association
Barbara S. Wiggins et al.
CIRCULATION (2016)
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins et al.
LANCET (2016)
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
S. Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data
K. L. Lentine et al.
TRANSPLANTATION PROCEEDINGS (2016)
Big Data in Organ Transplantation: Registries and Administrative Claims
A. B. Massie et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Trends in Kidney Transplant Outcomes in Older Adults
Mara A. McAdams-DeMarco et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient
Christoph Wanner et al.
KIDNEY INTERNATIONAL (2014)
Understanding Medical Care of Transplant Recipients through Integrated Registry and Pharmacy Claims Data
Krista L. Lentine et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation
Krista L. Lentine et al.
CIRCULATION (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
New-Onset Diabetes Mellitus in Kidney Transplant Recipients Discharged on Steroid-Free Immunosuppression
Fu L. Luan et al.
TRANSPLANTATION (2011)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Impact of OATP transporters on pharmacokinetics
A. Kalliokoski et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients
B. L. Kasiske et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Statin Use Is Associated with Prolonged Survival of Renal Transplant Recipients
Franz Wiesbauer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Fluvastatin in the prevention of renal transplant vasculopathy:: Results of a prospective, randomized, double-blind, placebo-controlled trial
Daniel Seron et al.
TRANSPLANTATION (2008)
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
Pertti J. Neuvonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
New onset dyslipidemia after renal transplantation: Is there a difference between tacrolimus and cyclosporine?
S. Deleuze et al.
TRANSPLANTATION PROCEEDINGS (2006)
Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation
H Holdaas et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial
B Fellström et al.
KIDNEY INTERNATIONAL (2004)
Statin use after renal transplantation: a systematic quality review of trial-based evidence
KL Lentine et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Statins in solid organ transplantation: Is there an immunosuppressive effect?
JA Kobashigawa
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Effect of fluvastatin on cardiac outcomes in renal transplant recipients:: a multicentre, randomised, placebo-controlled trial
H Holdaas et al.
LANCET (2003)
Diabetes mellitus after kidney transplantation in the United States
BL Kasiske et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Effect of fluvastatin on acute renal allograft rejection: A randomized multicenter trial
H Holdaas et al.
KIDNEY INTERNATIONAL (2001)
The effects of lipid-lowering agents on acute renal allograft rejection
BL Kasiske et al.
TRANSPLANTATION (2001)
Safety and efficacy of simvastatin for hyperlipidemia in renal transplant recipients: A double-blind, randomized, placebo-controlled study
AF Santos et al.
TRANSPLANTATION PROCEEDINGS (2001)
The metabolic effects of cyclosporin and tacrolimus
P Marchetti et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2000)
Share Paper
